{
  "docId": "019de515-df71-7068-a98d-cc2a99c8892d",
  "docSlug": "c88233ba648814c9f5b65afc1926df6d",
  "documentTitle": "Adagio Therapeutics | Investor Conference Presentation Deck | 11 slides",
  "authorId": "adagio-therapeutics",
  "authorName": "Invivyd",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 11,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "problem_statement",
  "function": "diagnose_problem",
  "density": "overcrowded",
  "nDataPoints": 2,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de515-df71-7068-a98d-cc2a99c8892d/4",
  "deckHref": "/decks/019de515-df71-7068-a98d-cc2a99c8892d",
  "deckJsonHref": "/decks/019de515-df71-7068-a98d-cc2a99c8892d.json",
  "deckAnchorHref": "/decks/019de515-df71-7068-a98d-cc2a99c8892d#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.07,
        "x": 0.6,
        "y": 0.74
      },
      "kind": "list",
      "text": "Myeloma patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1659be59-be8b-4d7d-867a-4a50bd29ae3a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.08,
        "x": 0.82,
        "y": 0.83
      },
      "kind": "list",
      "text": "People with uncontrolled HIV",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bd128bdf-1376-49b3-903d-9133a5ac3378",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.08,
        "x": 0.82,
        "y": 0.39
      },
      "kind": "list",
      "text": "Organ transplant recipients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb818b21-e34c-4ce7-a7e7-d3ea49c0516b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.16,
        "x": 0.03,
        "y": 0.65
      },
      "kind": "list",
      "text": "People on immuno-suppressive drugs (e.g., MS, RA, IBD)",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "da45d2fc-7899-4f53-945d-1fb76bda9bf3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.09,
        "x": 0.44,
        "y": 0.51
      },
      "kind": "list",
      "text": "Bone marrow transplant recipients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e489d123-78e9-4e6e-9c1f-7e8940e32cde",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.09,
        "x": 0.24,
        "y": 0.74
      },
      "kind": "list",
      "text": "Leukemia patients",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f1b635ef-15e1-4421-82f9-f07ec0756acc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.01,
        "w": 0.52,
        "x": 0.04,
        "y": 0.89
      },
      "kind": "paragraph",
      "text": "Examples of populations that may not mount an adequate immune response to COVID-19 vaccination5",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "81ebe978-47ac-4ab3-871d-6b88ee77ff41",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.33,
        "x": 0.073,
        "y": 0.26
      },
      "kind": "paragraph",
      "text": "8-18M people in the U.S.1-3\n14M people in the E.U.4\nare estimated to be immunocompromised due to a\nmedical condition or immunosuppressive medication or\ntreatment",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bcd70bc9-e748-4d15-b35c-bce1cb96a257",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.96,
        "x": 0.03,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Sources: 1. Harpaz JAMA 2016; 2. Patel Emerg Infect Dis 2020; 3. U.S. Census Bureau Data; 4. European Cancer Patient Coalition: https://ecpc.org/joint-statement-on-the-protection-of-immunocompromised-patients/; 5. Lee BMJ 2022; https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html; MS, multiple sclerosis; RA, rheumatoid arthritis; IBD: inflammatory bowel disease",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4c23a786-6162-41e7-abce-ed341bb2f1b2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.09,
        "w": 0.889,
        "x": 0.046,
        "y": 0.08
      },
      "kind": "title",
      "text": "MILLIONS OF IMMUNOCOMPROMISED PEOPLE ARE IN URGENT NEED OF NEW THERAPEUTICS THAT PROVIDE PASSIVE IMMUNITY TO COVID-19",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1bddf89c-3dc3-4521-926b-fea3732efb01",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "4ff66768-f70c-4753-a4e4-f32737541748",
      "evidence": "paragraph/paragraph: 8-18M people in the U.S.1-3 14M people in the E.U.4 are estimated to be immunocompromised due to a medical condition or immunosuppressive medication or treatment",
      "confidence": 0.5
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 6,
      "from": 3,
      "beatId": "8b1e41e5-6fc4-4318-a405-3acb902895ca",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Problem",
      "beatSlug": "problem-agitate-solution-problem-identify-pain",
      "evidence": "Slides 3-6 detail the urgent need and complications for immunocompromised people.",
      "position": 0,
      "confidence": 0.9,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 6,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "4ce340fa-5923-4426-abff-c930e25c323b",
      "evidence": "Slides 3-6 emphasize the urgent need and complications, implying significant costs of inaction.",
      "position": 0,
      "objective": "What is the cost of not addressing the urgent need for new therapeutics?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}